2017
Association between length of stay and readmission for COPD.
Rinne ST, Graves MC, Bastian LA, Lindenauer PK, Wong ES, Hebert PL, Liu CF. Association between length of stay and readmission for COPD. The American Journal Of Managed Care 2017, 23: e253-e258. PMID: 29087152, PMCID: PMC6007823.Peer-Reviewed Original ResearchConceptsLonger LOSLength of stayHospital LOSPatient levelHospital levelChronic Obstructive Pulmonary Disease ReadmissionsShorter LOSRisk of readmissionAssociation of patientVeterans Affairs hospitalTransitional care practicesCause readmissionCOPD hospitalizationsCOPD readmissionsOdds ratioObservational studyReadmissionMultivariable regressionHigh riskCare practicesCOPDPatientsStayHospitalAssociation
2016
Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort
Callegari LS, Gray KE, Zephyrin LC, Harrington LB, Gerber MR, Cochrane BB, Weitlauf JC, Bean-Mayberry B, Bastian LA, Mattocks KM, Haskell SG, Katon JG. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort. The Gerontologist 2016, 56: s67-s77. PMID: 26768393, PMCID: PMC5881615, DOI: 10.1093/geront/gnv666.Peer-Reviewed Original ResearchConceptsPrevalence of hysterectomyEarly hysterectomyWomen veteransBirth cohortUnadjusted prevalenceWomen's Health Initiative clinical trialsBilateral salpingo-oophorectomyLogistic regression modelsPostmenopausal veteransSalpingo-oophorectomyMultinomial logistic regression modelsClinical trialsHigh prevalenceObservational studyHysterectomyHigher oddsElevated riskClinical practiceHealth needsCohortPrevalenceBaseline dataVeteransHealth risksRisk
2002
Hormone replacement therapy and the risk of death from breast cancer: A systematic review
Nanda K, Bastian LA, Schulz K. Hormone replacement therapy and the risk of death from breast cancer: A systematic review. American Journal Of Obstetrics And Gynecology 2002, 186: 325-334. PMID: 11854659, DOI: 10.1067/mob.2002.121077.Peer-Reviewed Original ResearchConceptsHormone replacement therapy usersHormone replacement therapyRisk of deathReplacement therapyBreast cancerTherapy usersCombined hormone replacement therapyRetrievable risk estimatesBreast cancer deathsCase-control studyRecency of useAscertainment of exposurePotential confoundersCancer deathRelative riskInclusion criteriaObservational studyHistologic conditionControl groupSystematic reviewProlonged durationTherapyProlonged useCancerRisk estimates